Page last updated: 2024-11-05

trihexyphenidyl and Acute Hypercapnic Respiratory Failure

trihexyphenidyl has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Three patients who had adult-onset dystonia and who were exhibiting respiratory problems were examined clinically and electrophysiologically."1.29Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study. ( Bergouignan, FX; Burbaud, P; Ferrer, X; Julien, J; Lagueny, A; Le Masson, G, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lagueny, A1
Burbaud, P1
Le Masson, G1
Bergouignan, FX1
Ferrer, X1
Julien, J1

Other Studies

1 other study available for trihexyphenidyl and Acute Hypercapnic Respiratory Failure

ArticleYear
Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:6

    Topics: Administration, Oral; Aged; Baclofen; Botulinum Toxins; Delayed-Action Preparations; Diaphragm; Dyst

1995